Is Gilead Sciences a Great Dividend Stock?

For a dividend stock to be great, it needs to offer investors strong, sustainable, and growing payouts. Today, we'll look at whether Gilead Sciences (NASDAQ: GILD) falls into the category of being a great dividend stock or not. While a lot of the hype surrounding the California-based biopharmaceutical company in recent weeks has been around remdesivir and the drug's potential to fight COVID-19, investors shouldn't neglect the dividend that the company pays.

With a yield of 3.5%, Gilead offers a better payout than the 2% that investors would typically expect from an average S&P 500 stock. But let's take a closer look to see how impressive Gilead's dividend really is, and whether the stock is a great option for income investors.

Continue reading

Source Fool.com